Roivant Q1 FY27 net loss widens to $290.61 million; revenue slips to $1.44 million
Reuters2026/08/06 11:07- Roivant posted a GAAP net loss of USD 290.61 million, widening from USD 273.91 million a year earlier; GAAP loss per share improved to USD 0.26 from USD 0.33.
- GAAP revenue slipped to USD 1.44 million from USD 2.17 million; GAAP R&D expense rose to USD 202.02 million from USD 152.92 million.
- GAAP G&A expense increased to USD 165.53 million from USD 134.02 million, largely on higher personnel costs tied to the Moderna settlement.
- Non-GAAP net loss widened to USD 243.69 million from USD 170.12 million; non-GAAP R&D climbed to USD 192.95 million from USD 141.03 million.
- Cash, cash equivalents, restricted cash and marketable securities totaled USD 3.9 billion; brepocitinib launch in dermatomyositis targeted by end-September 2026.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Securitize to Help Develop Dubai’s Regulated Tokenized Asset Market
Audley Travel to open concessions in nine John Lewis stores from November 2026
Tessin Nordic Holding announces extraordinary shareholder meeting
Will a 10-year US Treasury yield rising to 5.5% "attack" US stocks? Societe Generale warns: this could be the valuation tipping point.
Bokobza, Global Head of Asset Allocation at Société Générale, pointed out that if the 10-year U.S. Treasury yield reaches 5.5%, corporate profit growth will not be sufficient to offset the impact of rising rates on valuations, and the stock market will face substantial pressure. However, he believes that the upcoming rate hikes by the Federal Reserve and the European Central Bank will be relatively limited and will not disrupt the current economic cycle.
Crypto prices
More
